Boston Medical Center
420
46
62
262
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.3%
77 terminated/withdrawn out of 420 trials
77.3%
-9.2% vs industry average
8%
35 trials in Phase 3/4
35%
91 of 262 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (420)
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Role: lead
NAD Augmentation in Diabetes Kidney Disease
Role: collaborator
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Role: collaborator
Group-based Mindfulness for Chronic Pain in the Primary Care Setting
Role: lead
Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients
Role: lead
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
Role: lead
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
Role: lead
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
Role: lead
The Impact of Prehabilitation
Role: lead
Hypotensive Anesthesia for Orthognathic Surgery
Role: lead
More Individualized Care: Assessment and Recovery Through Engagement
Role: collaborator
Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits
Role: collaborator
Primary Connections for Youth and Families
Role: collaborator
Stepped Care for Posttraumatic Stress Disorder Study
Role: lead
Facilitating Autism Diagnosis in Shorter Timeframes by PCCs
Role: collaborator
Web-administered STAIR for Patients on Behavioral Health Waitlists
Role: lead
Improving PRO for Patients With Cancer Using ECAs and Data Visualization
Role: collaborator
Glaucoma Drop Aids Part 2
Role: lead
Carbohydrate Fluids and Post Operative Nausea and Vomiting
Role: lead
Cardiac Anodal Biphasic Pacing
Role: lead